论文部分内容阅读
连续或间断性静滴多巴酚丁胺(dobutamine)是进行性心衰病人缓解症状和缩短住院天数的常用辅助疗法。为评价连续静滴多巴酚丁胺对进展性心衰临床症状和死亡率的影响,作者进行了随机对照试验。 北美和欧洲13个国家95个中心的471例NYHAb或级的心衰病人纳入研究,左室射血分数25
Continuous or intermittent intravenous infusion of dobutamine is a common adjuvant therapy for symptomatic relief and shorter hospital stay in patients with progressive heart failure. To evaluate the effect of continuous intravenous dobutamine on clinical symptoms and mortality in patients with progressive heart failure, we conducted a randomized controlled trial. 471 patients with NYHAb or class heart failure in 95 centers in 13 countries across North America and Europe were enrolled in the study and their left ventricular ejection fraction